Pharmaceutical Regulation Conflict of Interest Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Nov 1, 2017)
Pharmaceutical Regulation Conflict of Interest Act
This bill amends the Ethics in Government Act of 1978 to prohibit a pharmaceutical regulator from using his or her position as regulator to influence any matter that provides a direct or substantial pecuniary benefit to a former employer or client. The position of pharmaceutical regulator refers to any officer or employee occupying a supervisory position within the Drug Enforcement Administration or the Food and Drug Administration.
The bill also prohibits such a pharmaceutical regulator from participating in matters involving an individual or entity with whom the pharmaceutical regulator is negotiating future employment.
The bill expands restrictions on lobbying by such pharmaceutical regulators following separation from employment with a pharmaceutical regulatory agency.
What just happenedNov 1, 2017
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Who’s behind it
- Introduced in SenateNov 1, 2017
- Nov 1, 2017IntroReferral
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Homeland Security and Governmental Affairs Committee - Nov 1, 2017IntroReferral10000
Introduced in Senate